日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

奈拉替尼对HER2突变型晚期胆道癌患者的抗肿瘤活性

Harding, James J; Piha-Paul, Sarina A; Shah, Ronak H; Murphy, Jessica J; Cleary, James M; Shapiro, Geoffrey I; Quinn, David I; Braña, Irene; Moreno, Victor; Borad, Mitesh; Loi, Sherene; Spanggaard, Iben; Park, Haeseong; Ford, James M; Arnedos, Mónica; Stemmer, Salomon M; de la Fouchardiere, Christelle; Fountzilas, Christos; Zhang, Jie; DiPrimeo, Daniel; Savin, Casey; Duygu Selcuklu, S; Berger, Michael F; Eli, Lisa D; Meric-Bernstam, Funda; Jhaveri, Komal; Solit, David B; Abou-Alfa, Ghassan K

Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

通过直接面向患者的宣传活动克服肿瘤基因组分析的障碍

Seyram A Doe-Tetteh ,Sabrina Y Camp ,Dalicia Reales ,Jett Crowdis ,Anne Marie Noronha ,Bernadette Wolff ,Tina Alano ,Jesse Galle ,S Duygu Selcuklu ,Agnes Viale ,Nicholas D Socci ,Ying L Liu ,William P Tew ,Carol Aghajanian ,Marc Ladanyi ,Meng Xiao He ,Saud H AlDubayan ,Roei David Mazor ,Ofer Shpilberg ,Oshrat Hershkovitz-Rokah ,Jose A Riancho ,Jose L Hernandez ,M Carmen Gonzalez-Vela ,Justin J Buthorn ,Manda Wilson ,Amy E Webber ,Mariko Yabe ,Kseniya Petrova-Drus ,Marc Rosenblum ,Benjamin H Durham ,Omar Abdel-Wahab ,Michael F Berger ,Mark T A Donoghue ,Andrew L Kung ,Julia Glade Bender ,Neerav N Shukla ,Samuel A Funt ,Ahmet Dogan ,Robert A Soslow ,Hikmat Al-Ahmadie ,Darren R Feldman ,Eliezer M Van Allen ,Eli L Diamond ,David B Solit

Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.

直肠癌新辅助治疗反应的基因组和转录组决定因素

Chatila Walid K, Kim Jin K, Walch Henry, Marco Michael R, Chen Chin-Tung, Wu Fan, Omer Dana M, Khalil Danny N, Ganesh Karuna, Qu Xuan, Luthra Anisha, Choi Seo-Hyun, Ho Yu-Jui, Kundra Ritika, Groves Katharine I, Chow Oliver S, Cercek Andrea, Weiser Martin R, Widmar Maria, Wei Iris H, Pappou Emmanouil P, Nash Garrett M, Paty Philip B, Shi Qian, Vakiani Efsevia, Duygu Selcuklu S, Donoghue Mark T A, Solit David B, Berger Michael F, Shia Jinru, Pelossof Raphael, Romesser Paul B, Yaeger Rona, Smith J Joshua, Schultz Nikolaus, Sanchez-Vega Francisco, Garcia-Aguilar Julio

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

作者更正:RET驱动的肺癌和甲状腺癌中RET抑制剂耐药性的演变

Rosen, Ezra Y; Won, Helen H; Zheng, Youyun; Cocco, Emiliano; Selcuklu, Duygu; Gong, Yixiao; Friedman, Noah D; de Bruijn, Ino; Sumer, Onur; Bielski, Craig M; Savin, Casey; Bourque, Caitlin; Falcon, Christina; Clarke, Nikeysha; Jing, Xiaohong; Meng, Fanli; Zimel, Catherine; Shifman, Sophie; Kittane, Srushti; Wu, Fan; Ladanyi, Marc; Ebata, Kevin; Kherani, Jennifer; Brandhuber, Barbara J; Fagin, James; Sherman, Eric J; Rekhtman, Natasha; Berger, Michael F; Scaltriti, Maurizio; Hyman, David M; Taylor, Barry S; Drilon, Alexander

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

RET 抑制剂在 RET 驱动的肺癌和甲状腺癌中的耐药性演变

Ezra Y Rosen #, Helen H Won #, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong, Noah D Friedman, Ino de Bruijn, Onur Sumer, Craig M Bielski, Casey Savin, Caitlin Bourque, Christina Falcon, Nikeysha Clarke, Xiaohong Jing, Fanli Meng, Catherine Zimel, Sophie Shifman, Srushti Kittane, Fan Wu,

Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis

靶向 Aurora B 激酶可通过增强 BIM 和 PUMA 介导的细胞凋亡来预防和克服肺癌对 EGFR 抑制剂的耐药性。

Kosuke Tanaka,Helena A Yu,Shaoyuan Yang,Song Han,S Duygu Selcuklu,Kwanghee Kim,Shriram Ramani,Yogesh Tengarai Ganesan,Allison Moyer,Sonali Sinha,Yuchen Xie,Kota Ishizawa,Hatice U Osmanbeyoglu,Yang Lyu,Nitin Roper,Udayan Guha,Charles M Rudin,Mark G Kris,James J Hsieh,Emily H Cheng

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

转移性实体瘤患者的肿瘤分数指导的无细胞DNA分析

Tsui, Dana W Y; Cheng, Michael L; Shady, Maha; Yang, Julie L; Stephens, Dennis; Won, Helen; Srinivasan, Preethi; Huberman, Kety; Meng, Fanli; Jing, Xiaohong; Patel, Juber; Hasan, Maysun; Johnson, Ian; Gedvilaite, Erika; Houck-Loomis, Brian; Socci, Nicholas D; Selcuklu, S Duygu; Seshan, Venkatraman E; Zhang, Hongxin; Chakravarty, Debyani; Zehir, Ahmet; Benayed, Ryma; Arcila, Maria; Ladanyi, Marc; Funt, Samuel A; Feldman, Darren R; Li, Bob T; Razavi, Pedram; Rosenberg, Jonathan; Bajorin, Dean; Iyer, Gopa; Abida, Wassim; Scher, Howard I; Rathkopf, Dana; Viale, Agnes; Berger, Michael F; Solit, David B

Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study

连续cfDNA NGS在I期篮式试验患者前瞻性基因组分析中的应用

Smyth, Lillian M; Reichel, Jonathan B; Tang, Jiabin; Patel, Juber Ahamad A; Meng, Fanli; Selcuklu, Duygu S; Houck-Loomis, Brian; You, Daoqi; Samoila, Aliaksandra; Schiavon, Gaia; Li, Bob T; Razavi, Pedram; Piscuoglio, Salvatore; Reis-Filho, Jorge S; Taylor, Barry S; Baselga, José; Solit, David B; Hyman, David M; Berger, Michael F; Chandarlapaty, Sarat

Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangiocarcinoma Harboring FGFR2 Alterations

无创检测携带FGFR2改变的胆管癌患者对FGFR抑制剂的多克隆获得性耐药

Varghese, Anna M; Patel, Juber; Janjigian, Yelena Y; Meng, Fanli; Selcuklu, S Duygu; Iyer, Gopakumar; Houck-Loomis, Brian; Harding, James J; O'Reilly, Eileen M; Abou-Alfa, Ghassan K; Lowery, Maeve A; Berger, Michael F